Cargando…

Corticosteroids for COVID-19: the search for an optimum duration of therapy

Detalles Bibliográficos
Autores principales:	Mishra, Gyanshankar P, Mulani, Jasmin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2021
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7836750/ https://www.ncbi.nlm.nih.gov/pubmed/33248469 http://dx.doi.org/10.1016/S2213-2600(20)30530-0

Ejemplares similares

Current updates in tuberculosis
por: Mishra, Gyanshankar
Publicado: (2017)

Inhaled Corticosteroids and COVID-19
por: Lipworth, Brian, et al.
Publicado: (2020)

Ten reasons why corticosteroid therapy reduces mortality in severe COVID-19
por: Añón, José M., et al.
Publicado: (2021)

The ten reasons why corticosteroid therapy reduces mortality in severe COVID-19. Author's reply
por: Meduri, G. Umberto, et al.
Publicado: (2021)

Caution When Comparing the Impact of Corticosteroids in COVID-19
por: Confalonieri, Marco, et al.
Publicado: (2021)

Corticosteroids and the hyper-inflammatory phase of the COVID-19 disease
por: Taboada, Manuel, et al.
Publicado: (2020)

Caution against corticosteroid-based COVID-19 treatment
por: Tang, Chong, et al.
Publicado: (2020)

Reply to Lipworth et al.: Inhaled Corticosteroids and COVID-19
por: Maes, Tania, et al.
Publicado: (2020)

Corticosteroid Plus Tocilizumab in COVID-19: When Two Is Better Than One
por: Kow, Chia Siang, et al.
Publicado: (2021)

Adjunctive corticosteroid treatment for organizing pneumonia in COVID-19 patients with persistent respiratory failure
por: Segala, Francesco Vladimiro, et al.
Publicado: (2021)

Accelerated progression of pulmonary tuberculosis in a COVID-19 patient after corticosteroid treatment
por: Liu, Wang-Da, et al.
Publicado: (2022)

A case of COVID-19 with long duration of viral shedding
por: Wang, Changtai, et al.
Publicado: (2021)

Corticosteroids and COVID-19: What Could Be the Best Bet in Treating Active Glomerular Diseases in Patients With Concomitant Early COVID-19?
por: Nayak, Saurabh, et al.
Publicado: (2021)

COVID-19 and upper respiratory tract: Collecting swab specimens from patients inhaling corticosteroids
por: Siniorakis, Eftychios, et al.
Publicado: (2020)

Erratum: COVID-19–related Genes in Sputum Cells in Asthma: Relationship to Demographic Features and Corticosteroids
por: Peters, Michael C.
Publicado: (2020)

Duration of effectiveness of vaccination against COVID-19 caused by the omicron variant
por: Higdon, Melissa M, et al.
Publicado: (2022)

Corticosteroids for critically ill COVID-19 patients with cytokine release syndrome: a limited case series
por: Yang, Stephen Su, et al.
Publicado: (2020)

Duration of Culturable SARS-CoV-2 in Hospitalized Patients with Covid-19
por: Kim, Min-Chul, et al.
Publicado: (2021)

More data are required for incubation period, infectivity, and quarantine duration for COVID-19
por: Cimolai, Nevio
Publicado: (2020)

Inhaled Corticosteroids and Adult Asthma
por: Boulet, Louis-Philippe, et al.
Publicado: (2019)

When to call it off: Defining the role of low-dose corticosteroids in thwarting the progression of non-severe COVID-19
por: Almas, Talal, et al.
Publicado: (2021)

Risk of hepatitis B reactivation associated with treatment against SARS-CoV-2 (COVID-19) with corticosteroids()
por: Varona Pérez, J., et al.
Publicado: (2020)

Partitioning Mechanical Ventilator Duration in COVID-19–related Acute Respiratory Distress Syndrome
por: Gendreau, Ségolène, et al.
Publicado: (2022)

Corticosteroids are effective in the treatment of viruspositive post‐COVID myoendocarditis with high autoimmune activity
por: Blagova, Olga, et al.
Publicado: (2023)

Relapse of SARS upon tapering corticosteroid
por: Chien, Jung-Yien, et al.
Publicado: (2004)

Optimum cardiovascular risk prediction algorithm for South-Asians – Are WHO risk prediction charts really the right answer?
por: Bansal, Manish, et al.
Publicado: (2016)

High-Flow Nasal Cannula Failure Odds Is Largely Independent of Duration of Use in COVID-19
por: Gershengorn, Hayley B., et al.
Publicado: (2022)

Corticosteroid outcome may be dependent of duration of use in severe COVID-19
por: Kim, Jin Hyoung, et al.
Publicado: (2023)

Different effect of inhaled and systemic corticosteroids on the outcome of COVID-19 among patients with asthma
por: Hsu, Chi-Kuei, et al.
Publicado: (2022)

In search of other respiratory viruses during the COVID-19 pandemic()
por: Saint-Pierre Contreras, G., et al.
Publicado: (2021)

Inhaled corticosteroids and angiotensin-converting enzyme-2 in COPD
por: Lipworth, Brian, et al.
Publicado: (2021)

Preterm Birth: Effect of Corticosteroids or Immediate Cord Clamping?
por: Hutchon, David, et al.
Publicado: (2006)

On the use of corticosteroids for 2019-nCoV pneumonia
por: Shang, Lianhan, et al.
Publicado: (2020)

Reply to Boulet and Nair: Inhaled Corticosteroids and Adult Asthma
por: Beasley, Richard, et al.
Publicado: (2019)

Driving Pressure in COVID-19 Acute Respiratory Distress Syndrome Is Associated with Respiratory Distress Duration before Intubation
por: Tsolaki, Vasiliki S., et al.
Publicado: (2021)

Reply to “Different effect of inhaled and systemic corticosteroids on the outcome of COVID-19 among patients with asthma”
por: Feng, Lan, et al.
Publicado: (2022)

Optimum duration of breast cancer follow-up: a continuing controversy
por: Maraqa, L, et al.
Publicado: (2007)

Optimum culture duration for growing oocytes to attain meiotic and fertilization competence
por: YAMOCHI, Takayuki, et al.
Publicado: (2017)

Low risk of transmission of SARS-CoV2 and effective endotherapy for gastrointestinal bleeding despite challenges supports resuming optimum endoscopic services
por: Agarwal, Ashish, et al.
Publicado: (2021)

Duration of Breast-Feeding and PBBs
por: Rogan, W
Publicado: (2002)

Cannot write session to /tmp/vufind_sessions/sess_b5kc78kf15dagcg3pror09m82k